JAPAN · MEDICAL DEVICES · MARKET ANALYSIS

Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

Japan's medical devices market reached roughly JPY 6.0 trn (USD ~40 bn) in 2023 [MHLW 2024] — the world's third-largest — with demand structurally underwritten by the oldest population on earth: 36.3 million people aged 65+, 29.3% of the total [Govt stats 2024]. The FY2026 reimbursement reform pairs a +3.09% fee-body increase with the first-ever reverse-margin correction, redrawing device economics just as the aging cohort enters its highest-utilisation decade [Chuikyo 2025].

Executive summary

Japan is the world's third-largest medical device market at approximately $40 billion. The market is characterised by conservative procurement processes, lengthy regulatory approval timelines under PMDA, and strong preference for relationship-based sales through specialised distributors. US and European multinationals dominate capital equipment segments, while domestic players (Terumo, Olympus, Hoya) lead in specialty devices — notably endoscopy, where Olympus has 70%+ global market share. Japan's ageing population (29% over 65) is the primary structural demand driver. Recent regulatory reforms have aimed to reduce the "device lag" — the historically significant gap between US/EU approval and Japanese market entry. This report covers Japan's medical device market by segment, PMDA regulatory pathway, distribution channel structure, competitive landscape, and demand outlook driven by demographic ageing through 2026.

Report details

Published
2026-06-01
Pages
14
Format
PDF
Code
JP-MDV-XPL-D26-01
Market
Japan
Industry
Medical Devices
Year
2026

Table of contents · 12 sections

  1. 01 Executive summary
  2. 02 Strategic implications
  3. 03 Market sizing and segments
  4. 04 Segment economics
  5. 05 Aging-cohort demand structure
  6. 06 FY2026 reimbursement reform
  7. 07 Reimbursement policy timeline
  8. 08 Device lag and price gap
  9. 09 Competitive landscape
  10. 10 SaMD and AI devices
  11. 11 5-year outlook and forecast
  12. 12 Methodology and sources

The full report is available to subscribers and buyers. The executive summary above is free to read.

Key questions

How fast is Japan's old-age dependency ratio rising?

The old-age dependency ratio is projected to climb from 39% in 2020 to 71% by 2040, according to KIRA's 2026 market report (Govt stats 2024).

Source: Govt stats 2024, 2040 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How many people in Japan are aged 65 and over?

Japan had 36.3 mn people aged 65 and over in 2024, 29.3% of the population, according to KIRA's 2026 market report (Govt stats 2024).

Source: Govt stats 2024, 2024 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How big is Japan's in-vitro diagnostics market?

Japan's IVD market is projected to grow from USD 4.84 bn to USD 7.02 bn by 2033, a 4.2% CAGR, according to KIRA's 2026 market report.

Source: KIRA research, 2033 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How large will Japan's medical device market be by 2030?

KIRA estimates Japan's medical device market at about USD 62 bn by 2030, from USD 40 bn in 2023, according to KIRA's 2026 market report.

Source: Kira estimates, 2030 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How big is Japan's medical devices market?

Japan's medical devices market reached roughly JPY 6.0 trn (USD ~40 bn) in 2023, the world's third-largest, according to KIRA's 2026 market report (MHLW 2024).

Source: MHLW 2024, 2023 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How did the FY2026 medical fee revision change the materials price?

The FY2026 materials price moved −0.01%, while the fee body rose 3.09%, the first positive whole-package revision in over a decade, according to KIRA's 2026 market report (Chuikyo 2025).

Source: Chuikyo 2025, 2026 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How much is the cost-effectiveness review cutting device prices?

The cost-effectiveness review produces a −4.29% median adjustment, as Chuikyo de-emphasises foreign reference pricing, according to KIRA's 2026 market report (Chuikyo 2025).

Source: Chuikyo 2025, 2025 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How much of Japan's medical device market is imported?

Imports reached JPY 3.32 trn in 2023, up 13.8% year on year, equal to 55% import dependency, according to KIRA's 2026 market report (Kira estimates).

Source: Kira estimates, 2023 · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

How many AI software medical devices are approved and reimbursed in Japan?

About 100 AI software medical devices have PMDA approval and insurance coverage, with imaging AI the first reimbursed beachhead, according to KIRA's 2026 market report.

Source: KIRA research · KIRA report: Japan medical devices 2026: aging-cohort demand and the FY2026 reimbursement reform

More on Medical devices in Japan